Evidence map›Paper›PMID 40395930›Full record

ArticleMethodsX2025

A comprehensive protocol to study the effects of multilingualism on cognition and the brain in patients with progressive neurological diseases.

Christos Pliatsikas, Mark Antoniou, Jon Andoni Duñabeitia, Marco Calabria

Abstract read
In one paragraph

Article in MethodsX, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christos PliatsikasSchool of Psychology and Clinical Language Studies, University of Reading, UK.
Mark AntoniouThe MARCS Institute for Brain, Behaviour and Development, Western Sydney University, Australia.
Jon Andoni DuñabeitiaCentro de Investigación Nebrija en Cognición, Universidad Nebrija, Madrid, Spain.
Marco CalabriaFaculty of Health Sciences, Universitat Oberta de Catalunya, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multilingualism, the cognitively demanding experience of speaking multiple languages, has been linked to measurable effects on cognition and brain structure and function. These effects, attributed to the constant activation of multiple languages, may contribute to cognitive reserve, expressed as delayed cognitive decline in multilinguals diagnosed with progressive neurological diseases such as Alzheimer's, Huntington's and Parkinson's diseases, and Multiple Sclerosis. However, the evidence remains inconsistent due to methodological shortcomings, including variations in defining multilingualism and inadequate accounting for other lifestyle factors that may also promote cognitive reserve. To address these limitations, we developed a comprehensive protocol which incorporates detailed measurement of factors that are related to cognitive reserve, including multilingual experiences, standardized clinical and experimental cognitive assessments suitable for multilingual patients diagnosed with the above progressive neurological diseases, as well as thorough neuroimaging testing batteries. This protocol enables systematic investigation across linguistic and cultural contexts, facilitating cross-laboratory data pooling to advance understanding of multilingualism's neuroprotective potential in aging and disease. Its purpose is to spearhead an open-ended project which will keep adding to an increasing dataset of multilingual patients internationally; crucially, it sets a new standard in how to gather evidence investigating multilingualism as a factor contributing to cognitive reserve.

Indexed as

Alzheimer’sBilingualismCognitive reserveHuntington’sMultilingualismMultiple SclerosisNeuroimagingParkinson’s

Identifiers

PMID40395930
PMCPMC12090328

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.